EPO Patents = 25 (Patent Applications = 7)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 193(Granted Patents)

Forward Citations (Not Self Cited) = 184(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Frankfurt-am-Main, DE (2010)
Alzenau, DE (US) (2010)
Alzenau, DE (2002 - 2015)

Company Filing History:

22 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

Years Active: 2002-2015

Loading Chart...

Areas of Expertise:

PAR1 Inhibitors

Triazolopyridazines

Thiadiazole Derivatives

Dipeptidyl Peptidase Inhibitors

Benzimidazole Compounds

Pyridazinone Derivatives

Sulfonamide Pharmaceuticals

Acylurea Derivatives

Phenothiazine Derivatives

Aminoalkylthioxanthines

Cyclic Sulfonamides

Guanylate Cyclase Activators

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9079906 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2015-07-14),

2. 8871798 - Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors (2014-10-28),

3. 8853206 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2014-10-07),

4. 8598177 - Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2013-12-03),

5. 8466169 - [object Object] (2013-06-18),

6. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),

7. 8247452 - Urea- and urethane-substituted acylureas, process for their preparation and their use (2012-08-21),

8. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV (2012-08-07),

9. 8198272 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2012-06-12),

10. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),

11. 8163774 - Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments (2012-04-24),

12. 8138207 - Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions (2012-03-20),

13. 8076336 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2011-12-13),

14. 8003668 - Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders (2011-08-23),

15. 7968546 - Pyridazinone kinase inhibitors (2011-06-28),

Title: Karl Schoenafinger - Innovative Inventor from Alzenau

Introduction: Karl Schoenafinger is a renowned inventor hailing from Alzenau, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Karl Schoenafinger holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to innovation.

Career Highlights: With a career spanning over two decades, Karl Schoenafinger has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Karl Schoenafinger has collaborated with top companies, banks, and innovative startups to bring his inventions to the market, solidifying his reputation as a visionary inventor.

Conclusion: Karl Schoenafinger's passion for innovation and dedication to creating a sustainable future through his inventions make him a prominent figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

25 patents (EPO):

Please report any incorrect information to support@idiyas.com

7 patents pending (EPO):

Please report any incorrect information to support@idiyas.com